Signal
Unravel Health Secures 2.5 Million Euros to Launch Saliva-Based Home Hormone Diagnostics
- Category
- · Funding · Global
- Date
- October 21, 2026
- Source
- OVUM
Summary
Unravel Health has raised 2.5 million euros to commercialize its Micro Lab, a diagnostic device designed for rapid, saliva-based hormone testing. The platform aims to provide women with high-frequency endocrine data, transitioning clinical-grade analysis from centralized labs to daily at-home monitoring.
The company works in Diagnostics and Devices, and this round is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.